| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Sara De Biasi | Q82958176 |
| P2093 | author name string | G Guaraldi | |
| C Mussini | |||
| E Bianchini | |||
| A Cossarizza | |||
| M Nasi | |||
| L Gibellini | |||
| M Pinti | |||
| S Pecorini | |||
| V Bacca | |||
| P2860 | cites work | Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review | Q22242702 |
| Microbial translocation is a cause of systemic immune activation in chronic HIV infection | Q22251054 | ||
| Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 | ||
| HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors | Q24631745 | ||
| Monocytes as regulators of inflammation and HIV-related comorbidities during cART | Q27006827 | ||
| Understanding frailty, aging, and inflammation in HIV infection | Q27021143 | ||
| HIV-1 associated dementia: symptoms and causes | Q27473387 | ||
| HIV protease inhibitors: a review of molecular selectivity and toxicity | Q28082749 | ||
| γδ T Cells in HIV Disease: Past, Present, and Future | Q28084822 | ||
| Hypertriglyceridemia and waist circumference predict cardiovascular risk among HIV patients: a cross-sectional study | Q28744647 | ||
| A whole-genome association study of major determinants for host control of HIV-1 | Q29614891 | ||
| Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection | Q30400191 | ||
| Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease | Q33528999 | ||
| Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men | Q33684558 | ||
| Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults | Q33794374 | ||
| HIV infection is associated with an increased risk for lung cancer, independent of smoking | Q33834602 | ||
| Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection | Q33857515 | ||
| Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences | Q44927103 | ||
| The metabolic syndrome in HIV. | Q44967686 | ||
| Mitochondrial DNA haplogroups and highly active antiretroviral therapy-related lipodystrophy | Q45197763 | ||
| Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors | Q45199391 | ||
| Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders | Q45593571 | ||
| Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen. | Q45975911 | ||
| Liposome encapsulated all trans retinoic acid (ATRA) has enhanced immunomodulatory and inflammation reducing activities in mice model | Q50453437 | ||
| Independent predictors of metabolic syndrome in HIV-infected patients. | Q51007084 | ||
| Decreased mitochondrial DNA content in subcutaneous fat from HIV-infected women taking antiretroviral therapy as measured at delivery. | Q51373504 | ||
| Thymic output and functionality of the IL-7/IL-7 receptor system in centenarians: implications for the neolymphogenesis at the limit of human life. | Q51983138 | ||
| Single-Nucleotide Polymorphism–Defined Class I and Class III Major Histocompatibility Complex Genetic Subregions Contribute to Natural Long-term Nonprogression in HIV Infection | Q56837762 | ||
| Class of Antiretroviral Drugs and the Risk of Myocardial Infarction | Q57181081 | ||
| Inflammation, Immune Activation, and CVD Risk in Individuals With HIV Infection | Q58375394 | ||
| Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy | Q58377861 | ||
| Mitochondrial DNA Haplogroups and Incidence of Lipodystrophy in HIV-Infected Patients on Long-Term Antiretroviral Therapy | Q61399297 | ||
| Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study | Q61663307 | ||
| Fat distribution and metabolic changes in patients with HIV infection | Q73343740 | ||
| HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty | Q79827410 | ||
| Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey) | Q80277747 | ||
| Altered mitochondrial RNA production in adipocytes from HIV-infected individuals with lipodystrophy | Q81191238 | ||
| T cell subsets and mortality in older community-dwelling women | Q81305931 | ||
| HIV and aging: time for a new paradigm | Q84122386 | ||
| The mechanism of insulin resistance caused by HIV protease inhibitor therapy. | Q42802122 | ||
| Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations | Q42817110 | ||
| Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study | Q42992133 | ||
| Mitochondrial changes during D-drug-containing once-daily therapy in HIV-positive treatment-naive patients. | Q43157239 | ||
| Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compart | Q43491095 | ||
| Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy | Q44399171 | ||
| HIV protease inhibitors activate the unfolded protein response and disrupt lipid metabolism in primary hepatocytes. | Q44922052 | ||
| Frailty in elderly people | Q33902569 | ||
| Residual immune dysregulation syndrome in treated HIV infection | Q34020121 | ||
| Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats | Q34068440 | ||
| Adverse effects of antiretroviral therapy | Q34071132 | ||
| HIV Infection, Inflammation, Immunosenescence, and Aging | Q34150710 | ||
| Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? | Q34160020 | ||
| Persistent inflammation in HIV infection: established concepts, new perspectives | Q34401508 | ||
| Estrogen deficiency and bone loss: an inflammatory tale | Q34576622 | ||
| Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis | Q34580943 | ||
| A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals | Q34612071 | ||
| Mitochondria and HIV infection: the first decade. | Q34632929 | ||
| Body mass index, immune status, and virological control in HIV-infected men who have sex with men. | Q34653017 | ||
| HIV-associated lipodystrophy: impact of antiretroviral therapy. | Q34655845 | ||
| Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study | Q34656852 | ||
| Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo | Q34676901 | ||
| Plasma levels of soluble CD14 independently predict mortality in HIV infection | Q34764002 | ||
| Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence | Q34883074 | ||
| Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls | Q34916745 | ||
| The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation | Q35030011 | ||
| Verbal memory declines more rapidly with age in HIV infected versus uninfected adults | Q35050070 | ||
| Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment | Q35078313 | ||
| Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study | Q35189974 | ||
| HIV therapy, metabolic syndrome, and cardiovascular risk | Q35194399 | ||
| The relationship of physical performance with HIV disease and mortality | Q35234602 | ||
| HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease? | Q35276630 | ||
| An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy | Q35290337 | ||
| Energy expenditure in HIV infection | Q35578690 | ||
| Gut epithelial barrier and systemic inflammation during chronic HIV infection | Q35648710 | ||
| Updated research nosology for HIV-associated neurocognitive disorders | Q35755761 | ||
| Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations. | Q35767876 | ||
| A new frailty syndrome: central obesity and frailty in older adults with the human immunodeficiency virus | Q35827873 | ||
| Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation | Q35878906 | ||
| Weight change after antiretroviral therapy and mortality | Q35974655 | ||
| Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load | Q36331886 | ||
| Inflammation markers predicting frailty and mortality in the elderly. | Q36388062 | ||
| Anti-HIV drugs and the mitochondria | Q36510285 | ||
| Accelerated immune senescence and HIV-1 infection | Q36738887 | ||
| Physiologic frailty and fragility fracture in HIV-infected male veterans | Q36789908 | ||
| Metabolic syndrome in human immunodeficiency virus positive patients | Q36862157 | ||
| More than osteoporosis: age-specific issues in bone health. | Q36877351 | ||
| Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. | Q36936337 | ||
| Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system | Q36938343 | ||
| Cancer risk among the HIV-infected elderly in the United States | Q36957697 | ||
| Failure to restore the Vgamma2-Jgamma1.2 repertoire in HIV-infected men receiving highly active antiretroviral therapy (HAART). | Q37016878 | ||
| Arterial inflammation in patients with HIV. | Q37046942 | ||
| Inflammaging as a major characteristic of old people: can it be prevented or cured? | Q37073898 | ||
| Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy | Q37086701 | ||
| T-lymphocytes expressing CC chemokine receptor-5 are increased in frail older adults | Q37144151 | ||
| Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease | Q37390635 | ||
| Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects | Q37418053 | ||
| Epidemiology, assessment, and management of excess abdominal fat in persons with HIV infection. | Q37706091 | ||
| T cell homeostasis in centenarians: from the thymus to the periphery. | Q37730121 | ||
| HIV, aging, and cognition: emerging issues. | Q38131942 | ||
| Cardiovascular diseases and diabetes as economic and developmental challenges in Africa | Q38165371 | ||
| Morbidity in older HIV-infected patients: impact of long-term antiretroviral use. | Q38206673 | ||
| Multimorbidity and functional status assessment. | Q38215432 | ||
| HIV enteropathy and aging: gastrointestinal immunity, mucosal epithelial barrier, and microbial translocation | Q38215620 | ||
| Frailty in people aging with human immunodeficiency virus (HIV) infection. | Q38218045 | ||
| Different origin of adipogenic stem cells influences the response to antiretroviral drugs. | Q38559976 | ||
| Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now? | Q38596011 | ||
| Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity | Q38666958 | ||
| Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults. | Q38748465 | ||
| Assessment of second-line antiretroviral regimens for HIV therapy in Africa | Q38861912 | ||
| Coronary aging in HIV-infected patients | Q39035151 | ||
| Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis | Q39737305 | ||
| HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation | Q39958121 | ||
| Changes in mitochondrial RNA production in cells treated with nucleoside analogues. | Q40449711 | ||
| HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity | Q40510848 | ||
| A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity | Q40537680 | ||
| Successful treatment of HIV-1 infection increases the expression of a novel, short transcript for IL-18 receptor α chain. | Q41701694 | ||
| Effect of aging and human immunodeficiency virus infection on cognitive abilities | Q42288366 | ||
| Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. | Q42526719 | ||
| P433 | issue | 1 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 44-52 | |
| P577 | publication date | 2016-08-09 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Ageing and inflammation in patients with HIV infection | |
| P478 | volume | 187 |
| Q93047632 | A Natural Impact: NK Cells at the Intersection of Cancer and HIV Disease |
| Q94587776 | A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy |
| Q47204696 | Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation. |
| Q57455646 | Analyses of Mitochondrial DNA and Immune Phenotyping Suggest Accelerated T-Cell Turnover in Treated HIV |
| Q37529187 | Antiretroviral Treatment with Efavirenz Disrupts the Blood-Brain Barrier Integrity and Increases Stroke Severity. |
| Q64118863 | CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection |
| Q60920707 | Circulating Senescent T Cells Are Linked to Systemic Inflammation and Lesion Size During Human Cutaneous Leishmaniasis |
| Q64261666 | Enduring Challenge of Latent Tuberculosis in Older Nursing Home Residents: A Brief Review |
| Q40075058 | Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns |
| Q46176965 | Everyday Multitasking Abilities in Older HIV+ Adults: Neurobehavioral Correlates and the Mediating Role of Metacognition. |
| Q47570314 | Exploring viral reservoir: The combining approach of cell sorting and droplet digital PCR. |
| Q38654347 | Frontline Science: CXCR7 mediates CD14(+)CD16(+) monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS. |
| Q48352423 | Geriatric-HIV medicine: A science in its infancy |
| Q60049153 | Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000-2020 |
| Q54213057 | Gut Microbiota Contributes to Resistance Against Pneumococcal Pneumonia in Immunodeficient Rag-/- Mice. |
| Q92539113 | HIV-1 and Compromised Adult Neurogenesis: Emerging Evidence for a New Paradigm of HAND Persistence |
| Q89678950 | Hemostasis in elderly patients with human immunodeficiency virus (HIV) infection-Cross-sectional study |
| Q92547767 | Human Immunodeficiency Virus Infection and Diverse Physical Health Outcomes: An Umbrella Review of Meta-analyses of Observational Studies |
| Q39451386 | Human T cell immunosenescence and inflammation in aging |
| Q61454355 | Hyperglycemia and Risk of All-cause Mortality Among People Living With HIV With and Without Tuberculosis Disease in Myanmar (2011-2017) |
| Q48330936 | Immune activation despite preserved CD4 T cells in perinatally HIV-infected children and adolescents. |
| Q48143613 | Immunosenescence: the importance of considering age in health and disease |
| Q90290758 | Immunotherapy in People With HIV and Cancer |
| Q56337838 | Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty |
| Q39309490 | Inflammation and premature aging in advanced chronic kidney disease |
| Q58763014 | Insulin Resistance in HIV-Patients: Causes and Consequences |
| Q96301291 | Letter to the Editor on "Bonafè M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev" |
| Q50146220 | Liver macrophage-associated inflammation correlates with SIV burden and is substantially reduced following cART. |
| Q60046427 | Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging |
| Q38831718 | Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment |
| Q64118578 | Release of Soluble Insulin Receptor From Neurons by Cerebrospinal Fluid From Patients With Neurocognitive Dysfunction and HIV Infection |
| Q91537101 | Retrotransposition and senescence in mouse heart tissue by viral protein R of human immunodeficiency virus-1 |
| Q37712593 | Role of Natural Killer Cells in HIV-Associated Malignancies. |
| Q89771266 | Social support moderates D-dimer and self-rated successful aging within people with HIV and older adults |
| Q60046671 | Stronger Association between Insomnia Symptoms and Shorter Telomere Length in Old HIV-Infected Patients Compared with Uninfected Individuals |
| Q90282547 | Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy |
| Q91798649 | Supporting choices about HIV disclosure in the workplace: A cross-Canada survey of strategies |
| Q44174979 | T Follicular Helper Cells and B Cell Dysfunction in Aging and HIV-1 Infection. |
| Q61812140 | Targeted Mitochondrial COQ Delivery Attenuates Antiretroviral-Drug-Induced Senescence of Neural Progenitor Cells |
| Q64076275 | Targeting the HIV-infected brain to improve ischemic stroke outcome |
| Q38714925 | Tat-Mediated Induction of miRs-34a & -138 Promotes Astrocytic Activation via Downregulation of SIRT1: Implications for Aging in HAND. |
| Q40296944 | Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity. |
| Q53075373 | The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity. |
| Q89805370 | The Role of Physical Activity for the Management of Sarcopenia in People Living with HIV |
| Q92350467 | Trends of hospitalisations rates in a cohort of HIV-infected persons followed in an Italian hospital from 1998 to 2016 |
Search more.